Gadolinium-based nanoparticles are novel objects with interesting physical properties, allowing their use for diagnostic and therapeutic applications. Gadolinium-based nanoparticles were imaged following intravenous injection in healthy rats and rats grafted with 9L gliosarcoma tumors using magnetic resonance imaging and scintigraphic imaging. Quantitative biodistribution using gamma-counting of each sampled organ confirmed that these nanoparticles were rapidly cleared essentially by renal excretion. Accumulation of these nanoparticles in 9L gliosarcoma tumors implanted in the rat brain was quantitated. This passive and long-duration accumulation of gadolinium-based nanoparticles in tumor, which is related to disruption of the blood–brain barrier, is in good agreement with the use of these nanoparticles as radiosensitizers for brain tumors.
KimKY. Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine2007; 3(2): 103–110.
2.
FerrariM. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer2005; 5(3): 161–171.
3.
ManninoMChalmersAJ. Radioresistance of glioma stem cells: intrinsic characteristic or property of the microenvironment-stem cell unit?Mol Oncol2011; 5(4): 374–386.
4.
SteinigerSCJKreuterJKhalanskyAS. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer2004; 109(5): 759–767.
5.
AcharyaSSahooSK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev2011; 63(3): 170–183.
6.
SumerBGaoJ. Theranostic nanomedicine for cancer. Nanomedicine (Lond)2008; 3(2): 137–140.
7.
Le DucGMiladiIAlricC. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano2011; 5(12): 9566–9574.
MowatPMignotARimaW. In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells. J Nanosci Nanotechnol2011; 11(9): 7833–7839.
10.
BazziRFloresMALouisC. Synthesis and properties of europium-based phosphors on the nanometer scale: Eu2O3, Gd2O3:Eu, and Y2O3:Eu. J Coll Interface Sci2004; 273(1): 191–197.
11.
BridotJ-LFaureA-CLaurentS. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J Am Chem Soc2007; 129(16): 5076–5084.
12.
CoderreJRubinPFreedmanA. Selective ablation of rat brain tumors by boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys1994; 28(5): 1067–1077.
13.
BendaPSomedaKMesserJ. Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. J Neurosurg1971; 34(3): 310–323.
14.
KobayashiNAllenNClendenonNR. An improved rat brain-tumor model. J Neurosurg1980; 53(6): 808–815.
15.
PardridgeWM. Drug and gene delivery to the brain: the vascular route. Neuron2002; 36(4): 555–558.
16.
De JongWHBormPJA. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine2008; 3(2): 133–149.
17.
PardridgeWM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx2005; 2(1): 3–14.
18.
SegalMB. The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell Mol Neurobiol2000; 20(2): 183–196.
19.
PapadopoulosMCSaadounSBinderDK. Molecular mechanisms of brain tumor edema. Neuroscience2004; 129(4): 1011–1020.
20.
BriggerIMorizetJAubertG. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J Pharmacol Exp Ther2002; 303(3): 928–936.
21.
TsaiM-HCookJAChandramouliGVR. Gene Expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res2007; 67(8): 3845–3852.
22.
KimJHKhilMSKolozsvaryA. Fractionated radiosurgery for 9L gliosarcoma in the rat brain. Int J Radiat Oncol Biol Phys1999; 45(4): 1035–1040.
23.
SharmaUSSharmaAChauRI. Liposome-mediated therapy of intracranial brain tumors in a rat model. Pharm Res1997; 14(8): 992–998.
24.
HeldinC-HRubinKPietrasK. High interstitial fluid pressure – an obstacle in cancer therapy. Nat Rev Cancer2004; 4(10): 806–813.
25.
LiuH-LHuaM-YYangH-W. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci USA2010; 107(34): 15205–15210.
26.
HadjipanayisCGFellows-MayleWDelucaNA. Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery. Mol Ther2008; 16(11): 1783–1788.
27.
LongmireMChoykePLKobayashiH. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond)2008; 3(5): 703–717.
28.
ChoiHSLiuWMisraP. Renal clearance of quantum dots. Nat Biotechnol2007; 25(10): 1165–1170.
29.
FaureA-CDufortSJosserandV. Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings. Small2009; 5(22): 2565–2575.
